Mana.bio
Kira Radinsky is the CEO and CTO of Diagnostic Robotics and a Scientific Co-Founder at Mana.bio. Radinsky holds the position of Visiting Professor at the Technion - Israel Institute of Technology, where Radinsky also completed both a Bachelor of Science and a PhD in Computer Science. Additionally, Radinsky serves as a Technology Board Member at HSBC and is a Board Member at the Maccabi Health Data Science Institute.
This person is not in any offices
Mana.bio
Mana.bio is an AI based drug delivery startup, creating a platform for Lipid Nanoparticle (LNP) development for oligonucleotide therapies including mRNA-based therapeutics, vaccines and gene therapy.